We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
..rise in the share price today. GLA
What is with all the single digit 'A' trades ? Can anyone enlighten?
My thinking too. Re shorters Have seen some AT shenanigans in the last few weeks but there is a big buyer behind the market that’s been driving the action. It may be relatively small exposure but could prove challenging to close out without driving the SP considerably higher esp given the early recovery stage in the cycle. Few that have down averaged will be willing to release shares on the cheap.
I can't see an offer less than £2.00 as they previously rejected a 315p cash/share offer but you never know...
I wonder what Connor, Clark will do with their short position which is circa 0.7%. I would say they would be in a bit of a precarious position if they held on especially if Brexit goes through. IMHO
Agree they’re extremely vulnerable right now. The depressed SP is exactly where an acquirer would want it. Don’t think a successful offer would need to be over £2 either!
Spotted those chunky trades earlier today. I wonder.
I suppose if the Brexit deal goes ahead it's only a matter of time before we get a takeover offer here. I would of thought Mediclinic would be the prime candidate as S.A Government have expressed their concerns over the three largest healthcare providers having too much exposure in S.A so there is little room for expansion there. Also their Swiss operations appear to be improving so this may give them impetus to have a crack at Spire while their share price is greatly undervalued. I would have thought £2.00 plus is achievable and would still be £1.60 cheaper than the 30% they picked up at £3.60. Should be interesting here over the coming months...
Oh, just looked futher lots and lots of sells at 12:12. But as you say the shares price withstood, maybe mm's have a big order to fill, the market is a strange place. I wonder if someone with level two could throw some light on it?
Spit, not sure but looking at the time you posted I think you're talking about the 2x £800k, HL are showing 2x £3m sells at 4:28! Interesting open tomorrow I'm over 1k down so I'm just sitting and waiting, hoping that who ever is in Government uses Spire to reduce waiting lists over the winter.
Anyone have any info on all those sells....
Share price appears intact...
Spit
Comprehensive, high quality presentation.
However the group only generated £10m in free cash flow (after capex and finance charges) over the first 6 month period. “NHS remains challenging” they say and cost pressure on wages remain an issue plus leased hospital rental costs will keep on increasing as per the leases. Add to that increasing regulatory requirements and it’s an avoid from me. I was hoping for a bid from NMC or Mediclinic or a US outfit, but with so little free cash flow generated it’s difficult to see how any bid circa £1billion EV is funded from this capital intensive business. (Plus the long term hospital leases will probably have change of control clauses included in them which add to the complexity of any bid).
Well I have learned something of the Private Healthcare Business today and it was very interesting and well presented...seems like a well organised business...nothing there that would suggest a short term increase in the SP but most certainly a strong hold...
Looks like a good set of results from the figures in the highlights. Onwards and upwards hopefully. GLA
Looking good for open....
From today's RNS
Robust private growth of 4.1% sustained from H2 18.
Positive momentum on quality improvements with new Manchester hospital rated Outstanding. 81% of sites rated Good, Outstanding or equivalent (up from 74% in H1 18, 79% at FY18).
Long term pricing agreements signed with AXA PPP Healthcare and Bupa supporting our strategic focus on private patients
Digital strategy implementation underway with further rollout of consultant online booking, a successful pilot launch of the MySpire patient portal and a new Consultant App.
Purpose, our new cultural initiative to raise team engagement and our patient focus, launched across all hospitals and central functions
Group financial performance
3.4% revenue growth to £491.6m (2018: £475.6m)
Growth across all three payor groups: PMI sales rose 5.1%, Self-pay +1.4% and NHS +2.5%
Operating Profit growth to £51.0m (2018: £37.2m)
Net bank debt(4) lowered, with covenant leverage at 3.3x EBITDA (3.3x at end Dec 18, 3.0x at end June 18) versus limit of 4.0x
An interim dividend of 1.3 pence per ordinary share has been approved by the Board.
Justin Ash, Chief Executive Officer of Spire Healthcare, said: "This was a good performance with clear signs of our strategic and operational initiatives bearing fruit. We promised 2019 would be a year of stabilisation with revenue growth, continued quality improvement, cash generation and net debt reduction. All have been achieved in H1, with good operating profit performance.
Article below gives some insights in to the long awaited rise of the sp. personally (well down on this one) I'm hoping which ever party get in they will need to reduce waiting list before winter, thus sending more "jobs" our way. At 98p I thought about averaging down, wish I had.
https://www.sharecast.com/news/broker-recommendations-/broker-tips-entertainment-one-spire-healthcare-mitchells-butlers--7004716.html
It is very possible that news of the Interims has leaked over the past week or so given the change in share price sentiment. This has been hammered since they turned down the bid, but I suspect that one or two are still keen on hoovering Spire up. GLA
Given the news today on the target price, this is a cheap share......the new management seems to have settled the ship and making good progress with the new strategy & also buying shares. gla
Really?! Fosun make a bid for NMC private hospital group sparking a 40% jump in their share price and Spire's share price is flat on the same day?
Mediclinic didn't engage with the SPI bod before making their previous offer so I doubt they will in future if they decide to place another bid. The order book is being worked in the same way Laird and Cobham were before the bids were placed for them by Advent. Interesting to see if Advent intend on bidding for SPI, after all they already have a stake. The question is, if they do bid what will Mediclinic do?
Agreed, Director buying is definitely a green flag. The co must be near to its “close period” dealing cut off date so well done to the top two directors. The director share buying would tend to suggest we can look forward to a decent update on 16 Sept. but also means no current discussions with Mediclinic.
Nearly always a green flag for me. Doesn't matter how much we think they're both worth as individuals, c£50k is not pocket change. GLA
Those directors have convinced me to buy this pm. 5 weeks until half year results.
"If directors are not buying at these levels then they should be replaced by people that believe in the company."
Seems your will is their command, today's released RNS !!
The rejection of the Mediclinic offer was a serious misjudgement from the Spire bod in hindsight but they obviously believed the company was worth more and thought that Mediclinic would up their offer as they had already paid 360 per share for a 30% stake. I still believe an offer will come in due course and will just wait it out.
add to the misjudgement the rejection of 315 a share offer from mediclinic in 2017